globalhealthprogress.org

GENERAL
META
HTML
LINK ANALYSIS
SERVER

Globalhealthprogress.org receives any estimated 1,010 unique visitors and 110 unique page views per day. Revenue gained from these much visits may be $0 per day from various advertising sources. The estimated worth of site is $74. Similarweb global rank is 9,039,288. Maximum no. of users comes from .

DigitalOcean, LLC is ISP, hosted on IP 46.101.36.215 in Country United Kingdom.

Website Age n/a
Alexa Rank no-data
Country United Kingdom
IP Address 46.101.36.215

META INFORMATION

Title

Global Health Progress – Collaborating for a Sustainable Future

Description

Check out @GlobalHealth from @IFPMA to see how the innovative biopharmaceutical industry and partners are contributing towards the #SDGs and collaborating for a sustainable future https://globalhealthprogress.org/ #GlobalHealthProgress

Keywords

Content Type

utf-8

No	Meta Name	Value
1	viewport	width=device-width, initial-scale=1, shrink-to-fit=no

GENERAL HTML INFORMATION

Type	Status
HTML 5
Responsive Website

HTML SIZE INFORMATION

Text / Code Ratio 7.95 %

globalhealthprogress.org has a website text/code ratio of 7.95 %. Search engine crawlers tend to not pick up pages with inadequate content.

IMPORTANT HTML TAGS AND COUNTS

Titles

No	Text
1	Global health progress

No	Text
1	Global health progress is an interactive resource hub highlighting collaborations between the innovative biopharmaceutical industry and our partners to support the sdgs
2	Collaboratıon ıs at the heart of the sdgs
3	From supportıng people lıvıng wıth dıabetes ın vıetnam to targetıng malarıa ın the congo…
4	Reportıng on progress,callıng for contınued collaboratıve actıon
5	Catalysıng global actıon on ncds
6	Chartıng decades of advances ın global health progress

No	Text
1	Global biopharmaceutical ındustry commitmentto address coronavirus public health crisis
2	Our members & partners
3	Our collaboratıons
4	Our approach
5	Tb drug accelerator program
6	The london declaration on ntds
7	Access accelerated ınitiative

Text Styling

STRONG0
B4
EM0
I0
U0
CITE0

No	Text
1	PROGRESS
2	Global Health Progress
3	Access Accelerated Open Platform
4	50 Years of Global Health Progress

LINK ANALYSIS

Total Link Count: 31

Internal Link Count : 16

No	Text	Type
1	-	image
2	SDGs in Focus	text
3	Explore Our Collaborations	text
4	Explore our collaborations	text
5	-	image
6	OUR MEMBERS & PARTNERS Over 35 IFPMA members are working with partners from academia, development organizations, NGOs, foundations and other business sectors. Learn More	image
7	OUR COLLABORATIONS With over 250 collaborations, Global Health Progress details the scope, scale, and breadth of our collaborations working to strengthen health systems and expand access to quality healthcare. Learn More	image
8	OUR APPROACH Founded on patients need, we are strengthening health systems by developing and producing medicines to meet these needs and increasing the availability, accessibility and affordability of health services. Learn More	image
9	Explore our full directory of collaborations	text
10	TB Drug Accelerator Program Aiming to speed up the discovery and development of novel compounds against tuberculosis (TB).... AbbVie, AstraZeneca, Bayer AG, Eisai, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, MSD	image
11	The London Declaration on NTDs On 30 January 2012, pharmaceutical companies, donors, endemic countries and non-government organisations came... AbbVie, Bayer AG, Bristol-Myers Squibb, Eisai, GlaxoSmithKline, Johnson & Johnson, Merck, MSD, Novartis, Pfizer Inc, Sanofi	image
12	Access Accelerated Initiative Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting... Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol-Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., International Federation of Pharmaceutical Manufacturers & a*ociations, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, s*onogi & Co., Ltd., Sumitomo Dainippon, Takeda Pharmaceutical Company Limited, UCB	image
13	Explore our full directory of collaborations	text
14	Learn more	image
15	SDGs in Focus	text
16	Explore Our Collaborations	text

External Link Count : 15

No	Text	Type
1	Global Biopharmaceutical Industry Commitmentto Address Coronavirus Public Health Crisis As part of the global health community, biopharmaceutical companies are committed to playing the greatest possible role in the rapid, global response to COVID-19. Learn about our commitments and how we're leading the way in developing diagnostics, treatments and vaccines for COVID-19.	text
2	Learn more about the SDGs	text
3	Learn more	image
4	Learn more	image
5	Learn more	image
6	Explore the Access Accelerated Open Platform	text
7	Explore 50 Years of Global Health progress	text
8	-	empty
9	About IFPMA	text
10	LinkedIn	text
11	Twitter	text
12	Youtube	text
13	Facebook	text
14	Privacy Policy	text
15	Website by Wolf&Player	text